PE20220004A1 - Anticuerpos monoclonales especificos para el antigeno p del virus respiratorio sincicial humano (vrsh), producidos y secretados por hibridomas celulares, utiles para la deteccion y el diagnostico de la infeccion causada por vrsh - Google Patents
Anticuerpos monoclonales especificos para el antigeno p del virus respiratorio sincicial humano (vrsh), producidos y secretados por hibridomas celulares, utiles para la deteccion y el diagnostico de la infeccion causada por vrshInfo
- Publication number
- PE20220004A1 PE20220004A1 PE2021001936A PE2021001936A PE20220004A1 PE 20220004 A1 PE20220004 A1 PE 20220004A1 PE 2021001936 A PE2021001936 A PE 2021001936A PE 2021001936 A PE2021001936 A PE 2021001936A PE 20220004 A1 PE20220004 A1 PE 20220004A1
- Authority
- PE
- Peru
- Prior art keywords
- hrsv
- detection
- respiratory syncytial
- syncytial virus
- human respiratory
- Prior art date
Links
- 241000711920 Human orthopneumovirus Species 0.000 title abstract 5
- 238000001514 detection method Methods 0.000 title abstract 2
- 208000015181 infectious disease Diseases 0.000 title abstract 2
- 239000000427 antigen Substances 0.000 title 1
- 102000036639 antigens Human genes 0.000 title 1
- 108091007433 antigens Proteins 0.000 title 1
- 230000001413 cellular effect Effects 0.000 title 1
- 238000003745 diagnosis Methods 0.000 title 1
- 210000004408 hybridoma Anatomy 0.000 title 1
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 abstract 2
- 239000012634 fragment Substances 0.000 abstract 2
- 239000003550 marker Substances 0.000 abstract 2
- 102000004190 Enzymes Human genes 0.000 abstract 1
- 108090000790 Enzymes Proteins 0.000 abstract 1
- -1 RADIOISOTOPES Substances 0.000 abstract 1
- 239000012472 biological sample Substances 0.000 abstract 1
- 229960002685 biotin Drugs 0.000 abstract 1
- 235000020958 biotin Nutrition 0.000 abstract 1
- 239000011616 biotin Substances 0.000 abstract 1
- 238000000338 in vitro Methods 0.000 abstract 1
- 229910052751 metal Inorganic materials 0.000 abstract 1
- 239000002184 metal Substances 0.000 abstract 1
- 150000002739 metals Chemical class 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
- C07H21/04—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
- C07K16/1027—Paramyxoviridae, e.g. respiratory syncytial virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
- C12N2760/18534—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/12—Pulmonary diseases
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Virology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Cell Biology (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Pathology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pulmonology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- General Engineering & Computer Science (AREA)
- Communicable Diseases (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
Abstract
SE REFIERE A UN ANTICUERPO MONOCLONAL O UN FRAGMENTO DEL MISMO QUE SE UNE A LA PROTEINA P DEL VIRUS RESPIRATORIO SINCICIAL HUMANO (VRSh) QUE COMPRENDE UNA REGION VARIABLE DE LA CADENA PESADA QUE TIENE LA SECUENCIA SEQ ID NO: 5 Y UNA REGION VARIABLE DE LA CADENA LIVIANA QUE TIENE LA SECUENCIA SEQ ID NO: 6; EN DONDE EL ANTICUERPO O FRAGMENTO ADEMAS SE ENCUENTRA UNIDO A UN MARCADOR QUE PERMITE SU DETECCION, EN DONDE EL MARCADOR SE SELECCIONA DE FLUOROFOROS, BIOTINA, RADIOISOTOPOS, METALES Y ENZIMAS. TAMBIEN SE REFIERE A UN METODO IN VITRO Y/O EX VIVO DE DIAGNOSTICO DE INFECCION POR VRSh EN UNA MUESTRA BIOLOGICA.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CL2015002152A CL2015002152A1 (es) | 2015-07-31 | 2015-07-31 | Anticuerpos monoclonales específicos para el antígeno p del virus respiratorio sincicial humano (vrsh), producidos y secretados por hibridomas celulares, útiles para la detección y el diagnostico de la infección causada por vrsh |
| PCT/IB2016/054424 WO2017021815A2 (en) | 2015-07-31 | 2016-07-25 | Monoclonal antibodies specifically for the antigen p of the human respiratory syncytial virus, produced and secreted by the cells hybridomas, useful for detection and diagnostic of the infection caused by rsv |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20220004A1 true PE20220004A1 (es) | 2022-01-05 |
Family
ID=56610056
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2021001936A PE20220004A1 (es) | 2015-07-31 | 2016-07-25 | Anticuerpos monoclonales especificos para el antigeno p del virus respiratorio sincicial humano (vrsh), producidos y secretados por hibridomas celulares, utiles para la deteccion y el diagnostico de la infeccion causada por vrsh |
| PE2018000144A PE20180576A1 (es) | 2015-07-31 | 2016-07-25 | ANTICUERPOS MONOCLONALES ESPECIFICOS PARA EL ANTIGENO P DEL VIRUS RESPIRATORIO SINCICIAL HUMANO (VRSh), PRODUCIDOS Y SECRETADOS POR HIBRIDOMAS CELULARES, UTILES PARA LA DETECCION Y EL DIAGNOSTICO DE LA INFECCION CAUSADA POR VRSh |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2018000144A PE20180576A1 (es) | 2015-07-31 | 2016-07-25 | ANTICUERPOS MONOCLONALES ESPECIFICOS PARA EL ANTIGENO P DEL VIRUS RESPIRATORIO SINCICIAL HUMANO (VRSh), PRODUCIDOS Y SECRETADOS POR HIBRIDOMAS CELULARES, UTILES PARA LA DETECCION Y EL DIAGNOSTICO DE LA INFECCION CAUSADA POR VRSh |
Country Status (17)
| Country | Link |
|---|---|
| US (2) | US10858419B2 (es) |
| EP (2) | EP3517546B1 (es) |
| KR (1) | KR102679351B1 (es) |
| CN (1) | CN108474017B (es) |
| AR (1) | AR105541A1 (es) |
| BR (1) | BR112018002031A2 (es) |
| CA (1) | CA2994219C (es) |
| CL (1) | CL2015002152A1 (es) |
| CO (1) | CO2018001010A2 (es) |
| ES (2) | ES2786637T3 (es) |
| MX (2) | MX2018001244A (es) |
| PE (2) | PE20220004A1 (es) |
| PT (2) | PT3517546T (es) |
| RU (1) | RU2716990C2 (es) |
| UY (1) | UY36820A (es) |
| WO (1) | WO2017021815A2 (es) |
| ZA (1) | ZA201800938B (es) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102017127857B4 (de) * | 2017-11-24 | 2023-10-12 | Lipozyt Marker UG (haftungsbeschränkt) | Verwendung des ADIPOQ Genexpressionslevels zur Einordnung eines Probanden in Risikogruppen bei der Prognose oder Diagnose einer Diabetes mellitus Typ II Erkrankung |
| CA3111336A1 (en) * | 2018-09-03 | 2020-03-12 | Pontificia Universidad Catolica De Chile | Specific monoclonal antibody against the n antigen of human respiratory syncytial virus (hrsv) useful for treating infection, detection thereof and diagnosis |
| CL2018003869A1 (es) * | 2018-12-28 | 2021-01-15 | Univ Pontificia Catolica Chile | Anticuerpos monoclonales específicos para la proteína quimérica l del virus de la parainfluenza humana (piv), secuencias nucleotídicas; método y kit de diagnóstico de infección producida por piv |
| EP3825591A1 (en) | 2019-11-22 | 2021-05-26 | Hamilton Sundstrand Corporation | Hydraulic damping valve |
| CN113354734B (zh) * | 2021-07-14 | 2021-12-14 | 北京祥瑞生物制品有限公司 | 一种快速检测病毒的试剂盒及其制备方法 |
| CN115925909B (zh) * | 2022-09-27 | 2023-07-21 | 深圳重链生物科技有限公司 | 抗呼吸道合胞病毒抗体及其相关应用 |
| CN115838419B (zh) * | 2022-09-27 | 2023-06-30 | 深圳重链生物科技有限公司 | 抗呼吸道合胞病毒抗体及其相关应用 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5824307A (en) | 1991-12-23 | 1998-10-20 | Medimmune, Inc. | Human-murine chimeric antibodies against respiratory syncytial virus |
| US7223410B1 (en) * | 1994-08-05 | 2007-05-29 | Sanofi Pasteur Limited | Inactivated respiratory syncytial viral vaccines |
| US6258529B1 (en) * | 1994-12-01 | 2001-07-10 | Oravax, Inc. | PCR amplification of rearranged genomic variable regions of immunoglobulin genes |
| US7527787B2 (en) * | 2005-10-19 | 2009-05-05 | Ibc Pharmaceuticals, Inc. | Multivalent immunoglobulin-based bioactive assemblies |
| IL163646A0 (en) * | 2002-02-21 | 2005-12-18 | Vironovative Bv | Recombinant parainfluenza virus expression systemsand vaccines comprising heterologous antigens derived from metapneumovirus |
| JP2005533861A (ja) | 2002-07-25 | 2005-11-10 | メデュームン，インコーポレーテッド | 抗ＲＳＶ、抗ｈＭＰＶ、および抗ＰＩＶ抗体を使用するＲＳＶ、ｈＭＰＶ、およびＰＩＶの治療法と予防法 |
| EP1572108A4 (en) * | 2002-09-27 | 2008-09-17 | Medimmune Vaccines Inc | FUNCTIONAL MUTATIONS OF RSV (RESPIRATORY SYNCYTIAL VIRUS) |
| RU2008110058A (ru) * | 2005-08-15 | 2009-09-27 | Арана Терапьютикс Лимитед (Au) | Химерные антитела с областями приматов нового света |
| EP2363471B1 (en) * | 2008-10-31 | 2016-10-12 | Toray Industries, Inc. | Immunoassay method for human cxcl1 protein |
| CL2011003002A1 (es) * | 2011-11-25 | 2012-05-25 | Univ Pontificia Catolica Chile | Anticuerpo monoclonal o un fragmento del mismo que se une a la proteina m2-1 del virus respiratorio sincicial (vrs) humano; secuencias nucleotidicas; composicion farmaceutica; metodo de diagnostico de infeccion producida por vrs; kit; y uso de dicho anticuerpo para preparar un medicamento. |
-
2015
- 2015-07-31 CL CL2015002152A patent/CL2015002152A1/es unknown
-
2016
- 2016-07-25 RU RU2018103933A patent/RU2716990C2/ru active
- 2016-07-25 WO PCT/IB2016/054424 patent/WO2017021815A2/en active Application Filing
- 2016-07-25 CN CN201680052944.0A patent/CN108474017B/zh active Active
- 2016-07-25 CA CA2994219A patent/CA2994219C/en active Active
- 2016-07-25 ES ES18203701T patent/ES2786637T3/es active Active
- 2016-07-25 PT PT182037010T patent/PT3517546T/pt unknown
- 2016-07-25 ES ES16832387T patent/ES2784888T3/es active Active
- 2016-07-25 EP EP18203701.0A patent/EP3517546B1/en active Active
- 2016-07-25 KR KR1020187005939A patent/KR102679351B1/ko active IP Right Grant
- 2016-07-25 PT PT168323871T patent/PT3328884T/pt unknown
- 2016-07-25 PE PE2021001936A patent/PE20220004A1/es unknown
- 2016-07-25 MX MX2018001244A patent/MX2018001244A/es unknown
- 2016-07-25 US US15/748,979 patent/US10858419B2/en active Active
- 2016-07-25 EP EP16832387.1A patent/EP3328884B1/en active Active
- 2016-07-25 PE PE2018000144A patent/PE20180576A1/es unknown
- 2016-07-25 BR BR112018002031-1A patent/BR112018002031A2/pt active Search and Examination
- 2016-07-27 UY UY0001036820A patent/UY36820A/es not_active Application Discontinuation
- 2016-07-29 AR ARP160102326A patent/AR105541A1/es unknown
-
2018
- 2018-01-29 MX MX2022010471A patent/MX2022010471A/es unknown
- 2018-01-30 CO CONC2018/0001010A patent/CO2018001010A2/es unknown
- 2018-02-12 ZA ZA2018/00938A patent/ZA201800938B/en unknown
-
2020
- 2020-11-02 US US17/087,103 patent/US11873331B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| AR105541A1 (es) | 2017-10-11 |
| BR112018002031A2 (pt) | 2018-09-11 |
| KR20180030919A (ko) | 2018-03-26 |
| ZA201800938B (en) | 2019-07-31 |
| RU2018103933A3 (es) | 2019-08-28 |
| WO2017021815A3 (en) | 2017-05-11 |
| US11873331B2 (en) | 2024-01-16 |
| EP3328884A2 (en) | 2018-06-06 |
| EP3517546B1 (en) | 2020-02-26 |
| MX2018001244A (es) | 2018-04-24 |
| CA2994219A1 (en) | 2017-02-09 |
| CN108474017B (zh) | 2021-08-27 |
| US10858419B2 (en) | 2020-12-08 |
| CL2015002152A1 (es) | 2016-06-03 |
| RU2018103933A (ru) | 2019-08-28 |
| PE20180576A1 (es) | 2018-04-04 |
| EP3517546A1 (en) | 2019-07-31 |
| UY36820A (es) | 2017-01-31 |
| RU2716990C2 (ru) | 2020-03-17 |
| WO2017021815A2 (en) | 2017-02-09 |
| EP3328884B1 (en) | 2020-01-01 |
| KR102679351B1 (ko) | 2024-06-27 |
| US20180327483A1 (en) | 2018-11-15 |
| PT3517546T (pt) | 2020-05-22 |
| EP3328884A4 (en) | 2018-06-06 |
| PT3328884T (pt) | 2020-04-08 |
| CO2018001010A2 (es) | 2018-04-30 |
| ES2786637T3 (es) | 2020-10-13 |
| ES2784888T3 (es) | 2020-10-01 |
| CN108474017A (zh) | 2018-08-31 |
| CA2994219C (en) | 2024-02-20 |
| MX2022010471A (es) | 2022-09-19 |
| US20210070844A1 (en) | 2021-03-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20220004A1 (es) | Anticuerpos monoclonales especificos para el antigeno p del virus respiratorio sincicial humano (vrsh), producidos y secretados por hibridomas celulares, utiles para la deteccion y el diagnostico de la infeccion causada por vrsh | |
| CL2020001974A1 (es) | Anticuerpos anti-trem2 y métodos para utilizarlos. (divisional solicitud 201903093) | |
| PE20210132A1 (es) | Anticuerpos anti-cd3 y usos de estos | |
| AR095980A1 (es) | Anticuerpos biespecíficos específicos para fap (proteína de activación fibroblástica) y dr5 (receptor de muerte 5), anticuerpos específicos para dr5 y métodos de utilización | |
| PE20181054A1 (es) | Anticuerpos anti-cd19 humano humanizados y metodos de utilizacion | |
| BR112018016226A8 (pt) | Anticorpo antilipoarabinomanana (anti-lam) monoclonal humano, kit para detectar pelo menos um epítopo de lam, método para diagnosticar uma infecção de tuberculose ativa em um indivíduo, método para tratar uma infecção de tuberculose em um indivíduo, anticorpo monoclonal humano anti-lam e método de pré-concentração de lam a partir de uma amostra biológica | |
| PE20142041A1 (es) | Anticuerpos anti-il-36r | |
| PE20140882A1 (es) | Anticuerpos neutralizantes de citomegalovirus humano | |
| PE20140612A1 (es) | Estratificaciones a base de bcma y terapia para pacientes con mieloma multiple | |
| AR053948A1 (es) | Deteccion de un antigeno diana independientemente de la presencia o ausencia de un anticuerpo terapeutico correspondiente | |
| NZ594682A (en) | Fully human antibodies specific to cadm1 | |
| PE20141659A1 (es) | Dominios variables singulares anti-vgf fusionados con dominios de fc | |
| PE20220708A1 (es) | Anticuerpos anti-cd73 | |
| RU2011121818A (ru) | Способ иммунологического анализа белка cxcl1 человека | |
| PE20141683A1 (es) | Anticuerpos monoclonales especificos para el antigeno m2-1 del virus respiratorio sincicial (vrs) | |
| EA202192907A1 (ru) | Моноклональное антитело, которое специфически связывается с gitr | |
| ES2684173T3 (es) | Anticuerpos anti-XCR1 humano | |
| PE20181498A1 (es) | Anticuerpos monoclonales especificos para el antigeno piii de adenovirus humano (adv), producidos y secretados por hibridomas celulares, utiles para la deteccion y el diagnostico de la infeccion causada por adv | |
| CO2021008774A2 (es) | Anticuerpos monoclonales específicos para el antígeno pb2 del virus de la influenza humana (flu), secuencias nucleotídicas; método y kit de diagnóstico de infección producida por flu | |
| MD3365367T2 (ro) | Anticorpi monoclonali împotriva ploşniţelor de pat și procedee de obţinere și utilizare a acestora | |
| BR112018014250A2 (pt) | roedor, célula ou tecido isolados de roedor, célula imortalizada, célula-tronco embrionária de roedor, embrião de roedor, e, métodos para produção de um roedor e de um anticorpo | |
| PE20171734A1 (es) | Anticuerpos monoclonales especificos del antigeno m del virus metapneumovirus humano (hmpv) y su uso en un metodo de diagnostico | |
| CO2021008770A2 (es) | Anticuerpos monoclonales específicos para la proteína quimérica l del virus de la parainfluenza humana (piv), secuencias nucleotídicas; método y kit de diagnóstico de infección producida por piv | |
| PE20210103A1 (es) | Anticuerpo monoclonal de la glucoproteina g del virus de la laringotraqueitis infecciosa aviar y aplicaciones del mismo | |
| AR114380A1 (es) | VARIANTES DE Ab, ENSAYO, MÉTODO Y TRATAMIENTO DE LA ENFERMEDAD DE ALZHEIMER |